Search

everythinglearnresearchcommunity

for

Search:↓

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

Dutasteride use can lead to a stable decline in sexual function that is not affected by age or prostate size.

Oral finasteride and dutasteride may negatively affect erectile function in rats.

Finasteride helps improve treatment for benign prostatic hyperplasia.

5α-reductase inhibitors can cause serious and possibly lasting sexual and psychological side effects.

Regulatory challenges make developing combination therapies in urology difficult and costly.

Certain medications, especially 5-α reductase inhibitors and neuropsychiatric drugs, are often linked to erectile dysfunction.

5α-reductase inhibitors do not increase anaemia risk compared to α-blockers in men with BPH.

Men using 5-alpha reductase inhibitors for prostate issues may have a slightly higher risk of blood clots.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Drugs that block DHT production can effectively treat enlarged prostate and improve urinary issues with some sexual side effects.

Medicines called 5-alpha-reductase inhibitors, like finasteride and dutasteride, are useful for treating enlarged prostate and male pattern hair loss.

Taking both finasteride and dutasteride for prostate issues may raise the risk of heart problems.

The conclusion is that doctors should be careful when prescribing 5α-reductase inhibitors due to possible serious side effects, and they should discuss these risks with patients.

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

Finasteride is a safe and effective long-term treatment for prostate enlargement, reducing prostate volume and related symptoms.

5alpha-reductase inhibitors help treat hair loss and prostate issues but may cause sexual side effects.

Taking sildenafil and finasteride together is safe and improves urinary and sexual symptoms in BPH patients.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

5-alpha-reductase inhibitors help treat urinary symptoms from an enlarged prostate.

New compounds may help treat prostate issues without affecting androgen receptors.

Finasteride increases CD8+ T cells in BPH tissues.

Dutasteride is more effective than finasteride for treating BPH without extra safety risks.

Men on 5-alpha-reductase inhibitors might have worse COVID-19 outcomes.

5α-reductase inhibitors help treat prostate enlargement and hair loss but may cause side effects, requiring careful use.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

5α-reductase inhibitors like finasteride and dutasteride effectively treat BPH by reducing DHT levels.

5-alpha reductase inhibitors may have additional effects on cancer, mental health, heart health, and hormone levels beyond treating prostate enlargement.

PRP injections are safe but don't significantly improve Peyronie's Disease.

Blocking the enzyme that turns testosterone into DHT can safely and effectively treat enlarged prostate.